"SEIZMET TRIO 0.3: Triple Action Diabetes Management"

May 17, 2024

SEIZMET TRIO 0.3 

Glimepiride (2mg), Metformin SR (500mg), Voglibose (0.3mg)

Introduction

SEIZMET TRIO 0.3 is a powerful combination medication designed to manage type 2 diabetes effectively. It contains Glimepiride (2mg), Metformin SR (500mg), and Voglibose (0.3mg). This triple-action formula works synergistically to control blood sugar levels, reduce complications, and improve overall health for diabetic patients.

What is SEIZMET TRIO 0.3?

SEIZMET TRIO 0.3 is a triple-combination antidiabetic medication. Glimepiride is a sulfonylurea, Metformin SR is a biguanide, and Voglibose is an alpha-glucosidase inhibitor. Together, they offer comprehensive blood sugar control and help manage type 2 diabetes effectively.

How Does It Work?

  • Glimepiride (2mg): Stimulates the pancreas to release more insulin, thereby lowering blood sugar levels.
  • Metformin SR (500mg): Decreases glucose production in the liver and improves insulin sensitivity, allowing the body to use insulin more effectively.
  • Voglibose (0.3mg): Delays the absorption of carbohydrates from the intestines, preventing post-meal blood sugar spikes.

Benefits of SEIZMET TRIO 0.3

  1. Effective Blood Sugar Control: The combination of three antidiabetic agents provides superior blood sugar regulation compared to monotherapy.
  2. Reduced Risk of Complications: By maintaining optimal blood sugar levels, SEIZMET TRIO 0.3 reduces the risk of diabetes-related complications such as neuropathy, retinopathy, and cardiovascular diseases.
  3. Convenient Dosage: Combining three medications into one tablet simplifies the treatment regimen and improves patient adherence.

Usage and Dosage

SEIZMET TRIO 0.3 should be taken once or twice daily with meals, as directed by your healthcare provider. It is important to follow your doctor's instructions regarding the dosage and duration of treatment. Do not stop taking the medication without consulting your healthcare provider.

Side Effects

Common side effects include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. If you experience severe side effects such as hypoglycemia (low blood sugar), severe allergic reactions, or liver problems, seek immediate medical attention.

Conclusion

SEIZMET TRIO 0.3, with Glimepiride (2mg), Metformin SR (500mg), and Voglibose (0.3mg), offers a comprehensive approach to managing type 2 diabetes. Consult your healthcare provider to determine if this medication is suitable for you and enjoy the benefits of better blood sugar control and improved health.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

 

 

 

 

 

SHARE WITH